Fineotex Chemical: Business Overview & Financial Analysis
Fineotex Chemical Limited is an Indian multinational specialty chemical company headquartered in Mumbai, Maharashtra. Founded in 1979 by Surendra Tibrewala, the company manufactures customised performance chemicals across textiles, oil & gas, FMCG, cleaning & hygiene, water treatment and other industrial applications. Following the acquisition of a controlling stake in US-based CrudeChem Technologies Group, Fineotex operates manufacturing facilities across India, Malaysia and the United States and has a presence in around 70 countries.
Business Segment & Application Mix of Fineotex Chemical (FY2026)
Fineotex Chemical operates a diversified specialty chemicals portfolio spanning textile chemicals, oilfield chemicals, FMCG, cleaning & hygiene, and water treatment applications.
- Textile Chemicals – Specialty chemicals for pre-treatment, dyeing, printing, finishing and other textile processes
- Oil & Gas Chemicals – Advanced chemical fluid additives and specialty oilfield chemical solutions through CrudeChem Technologies Group
- FMCG, Cleaning & Hygiene – Chemicals used in disinfection, housekeeping, kitchen care, laundry and personal care applications
- Water Treatment Chemicals – Specialty polymers and performance chemicals used across water treatment applications
- Other Performance Chemicals – Specialty solutions for construction, paints and other industrial applications
The previously stated FY2026 revenue mix of 72% textile chemicals, 18% cleaning and hygiene chemicals and 10% water treatment and performance chemicals should not be treated as company-reported FY2026 data.
Fineotex’s business mix changed materially following the acquisition of a controlling stake in CrudeChem Technologies Group in December 2025. As a result, oil & gas specialty chemicals have become a major contributor to the consolidated business.
Product Portfolio & Technical Categories of Fineotex Chemical (FY2026)
Fineotex has developed a broad specialty chemicals platform across multiple end-user industries.
- Product Categories – 470+
- SKUs Across Product Categories – 1,600+
- Textile Chemicals – Pre-treatment, dyeing, printing, finishing and enzymes
- Oilfield Chemicals – Drilling fluids, cementing fluids, production chemicals and fracturing & stimulation solutions
- FMCG, Cleaning & Hygiene – Disinfection, housekeeping, kitchen care, laundry and personal care chemicals
- Water Treatment – Specialty polymers and other chemicals for water treatment applications
- Other Industrial Applications – Specialty chemicals for construction and performance chemicals for paints
- Key Accreditations – Bluesign, ZDHC, NABL and Star Export House, among other certifications and accreditations
The company’s expanded product platform reflects its strategy of moving beyond its traditional textile chemicals base into higher-value specialty chemistry applications.
Geographic Revenue Breakdown of Fineotex Chemical (Q1 FY2027)
Fineotex Chemical has become significantly more international following the consolidation of CrudeChem Technologies Group.
- Domestic Revenue Share – 23%
- International Revenue Share – 77%
- Countries Present – Around 70
- Dealer Network – 115+ dealers across Indian and international markets
- Q1 FY2027 Consolidated Revenue from Operations – Rs 376.63 crore
The Q1 FY2027 geographic revenue mix was 23% domestic and 77% international. This represents a materially different revenue profile from the earlier content, which stated 78% domestic and 22% international.
The change reflects the consolidation and rapid scaling of Fineotex’s US oilfield specialty chemicals operations.
Manufacturing Infrastructure & Facilities Scale of Fineotex Chemical (Q1 FY2027)
Fineotex Chemical operates a global manufacturing platform across India, Malaysia and the United States.
- Total Manufacturing Facilities – 5 plants
- Total Group Manufacturing Capacity – ~2,68,000 MTPA
- Ambernath, Maharashtra – 76,000 MTPA
- Mahape, Maharashtra – 36,500 MTPA
- Selangor, Malaysia – 6,500 MTPA
- CrudeChem Technologies, United States – ~1,48,000 MTPA across its US operations
- US Manufacturing Locations – Brookshire and Midland, Texas
- CrudeChem Capacity Utilisation – Around 63% in Q1 FY2027
During Q1 FY2027, Fineotex commissioned a major capacity expansion at its Texas facility. US manufacturing capacity increased to approximately 1,48,000 MTPA, taking total group capacity to around 2,68,000 MTPA.
Management indicated that the US operations were utilising around 63% of the expanded capacity, leaving headroom for further growth.
Latest Quarterly Financial Performance of Fineotex Chemical (Q1 FY2027)
Fineotex Chemical reported sharp growth in consolidated revenue, EBITDA and PAT during Q1 FY2027, supported by the full-quarter contribution from its US operations and growth in the domestic business.
- Consolidated Revenue from Operations – Rs 376.63 crore (+174.77% YoY vs Rs 137.07 crore)
- Total Revenue – Rs 386.72 crore (+164.94% YoY)
- Gross Profit – Rs 133.40 crore (+190.25% YoY)
- Gross Margin – 35.42% vs 33.53% in Q1 FY2026
- Consolidated EBITDA – Rs 59.14 crore (+134.70% YoY vs Rs 25.20 crore)
- Consolidated EBITDA Margin – 15.70% vs 18.38% in Q1 FY2026
- Profit Before Tax (PBT) – Rs 64.74 crore
- Consolidated Net Profit After Tax (PAT) – Rs 48.21 crore (+92.67% YoY vs Rs 25.03 crore)
- PAT Margin – 12.80% vs 18.26% in Q1 FY2026
- Return on Invested Capital (ROIC) – 33.06%
- Return on Capital Employed (ROCE) – 25.56%
- Return on Equity (ROE) – 19.63%
- Working Capital Cycle – 72 days
Revenue more than doubled year-on-year as Q1 FY2027 included the full-quarter contribution from Fineotex’s US operations. EBITDA increased 134.7% to Rs 59.14 crore and PAT increased 92.67% to Rs 48.21 crore.
However, the consolidated EBITDA margin declined to 15.70% from 18.38% in Q1 FY2026 as the addition of the US business changed the consolidated revenue and margin mix.
Consolidated Annual Financial Performance of Fineotex Chemical (FY2026)
Fineotex Chemical reported strong consolidated revenue growth during FY2026, aided by the addition of its US oilfield specialty chemicals business.
- Full Year Consolidated Revenue from Operations – Rs 772.23 crore (+45% YoY vs Rs 533.33 crore in FY2025)
- Full Year Gross Profit – Rs 254.86 crore vs Rs 205.71 crore in FY2025
- Full Year Gross Margin – 33.00% vs 38.57%
- Full Year Consolidated EBITDA – Rs 134.75 crore (+6% YoY vs Rs 127.23 crore)
- Full Year EBITDA Margin – 17.45% vs 23.85%
- Full Year Profit Before Tax – Rs 153.03 crore vs Rs 141.24 crore
- Full Year Consolidated PAT – Rs 125.01 crore (+14% YoY vs Rs 109.21 crore)
- Full Year PAT Margin – 16.19% vs 20.48%
Revenue from operations increased 45% year-on-year to Rs 772.23 crore, while PAT increased 14% to Rs 125.01 crore.
EBITDA growth was slower than revenue growth, resulting in the consolidated EBITDA margin declining from 23.85% in FY2025 to 17.45% in FY2026. The change partly reflects the altered business mix following the addition of the US oilfield chemicals operations.
Balance Sheet Structure & Capital Health Ratios of Fineotex Chemical (Q1 FY2027)
Fineotex Chemical continues to maintain a strong capital structure despite its recent international expansion and acquisition activity.
- Financial Position – Company identifies itself as debt-free
- FY2026 Shareholders’ Funds – Rs 939.73 crore, including non-controlling interest
- Long-Term Borrowings at FY2026-end – Rs 3.82 crore
- Short-Term Borrowings at FY2026-end – Rs 4.38 crore
- Cash & Cash Equivalents at FY2026-end – Rs 37.26 crore
- Bank Balances at FY2026-end – Rs 8.92 crore
- Non-Current Investments at FY2026-end – Rs 290.43 crore
- Current Investments at FY2026-end – Rs 27.05 crore
- Q1 FY2027 Working Capital Cycle – 72 days
- Long-Term ICRA Rating – A+ (Positive)
- Short-Term ICRA Rating – A1+ (Positive)
Fineotex’s financial investments and liquid assets remain significant relative to its borrowings, supporting its strong financial position.
The earlier figures of approximately Rs 280 crore in cash, Rs 520 crore of consolidated net worth, a 48-day working capital cycle and CRISIL/CARE ratings should not be used as Q1 FY2027 company-reported figures.
Strategic Expansion & Non-Textile Roadmap of Fineotex Chemical (FY2027–FY2028)
Fineotex Chemical is expanding beyond its traditional textile chemicals franchise through oil & gas, water treatment, FMCG, cleaning & hygiene and other specialty chemistry applications.
- Oil & Gas Revenue Contribution in Q1 FY2027 – Around 65% of consolidated revenue
- Oil & Gas Volume Contribution – Around 55%
- US Oilfield Chemicals Capacity – ~1,48,000 MTPA
- US Capacity Utilisation – Around 63% during Q1 FY2027
- Total Group Capacity – ~2,68,000 MTPA
- CrudeChem Product Portfolio – More than 90 oilfield and water-treatment chemicals
- Green Chemistry Share at CrudeChem – 44% of revenue
- Oilfield Chemicals Growth Opportunity – Management is targeting more than $200 million from the US oilfield chemicals opportunity by 2028
- Other Growth Areas – Water treatment, cleaning & hygiene, sustainable chemistry and increased wallet share from existing customers
Non-textile applications have become increasingly important following the CrudeChem acquisition. Management indicated that approximately 65% of Q1 FY2027 consolidated revenue was contributed by the oil & gas business.
The company is also evaluating further inorganic growth opportunities across specialty chemical segments.
Strategic Outlook & Management Commentary of Fineotex Chemical (Q1 FY2027 Concall)
Management’s growth strategy is centred on scaling the US oilfield chemicals business, improving capacity utilisation, expanding sustainable chemistry and strengthening Fineotex’s international specialty chemicals platform.
- CrudeChem FY2027 Revenue Aspiration – Around $100 million
- CrudeChem FY2028 Revenue Aspiration – Around $200 million
- US Oilfield Chemicals Capacity – ~1,48,000 MTPA following the latest expansion
- Q1 FY2027 US Capacity Utilisation – Around 63%
- Q1 FY2027 Oil & Gas Revenue Contribution – Around 65% of consolidated revenue
- International Expansion – Focus on expanding customer reach and wallet share across global markets
- Sustainable Chemistry – Continued expansion of green chemistry and eco-friendly product portfolios
- Inorganic Growth – Management continues to evaluate acquisition opportunities across high-growth specialty chemical segments
- Textile Chemicals – Management continues to focus on customer additions, export opportunities and sustainable textile chemistry
Management did not provide a fixed 25% to 27% consolidated EBITDA margin guidance. During the Q1 FY2027 call, management specifically explained that it does not want to set a rigid blended EBITDA margin because the margin depends on the mix of products, customers and volumes.
Fineotex’s strategy therefore centres on sustainable revenue and profit growth rather than maintaining a fixed consolidated margin percentage.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Fineotex Chemical Limited, Investor Presentation – July 2026
- Fineotex Chemical Limited, Q1 FY2027 Earnings Conference Call Transcript – 24 July 2026
- Fineotex Chemical Limited, Investor Presentation – May 2026
- Fineotex Chemical Limited, FY2026 Annual Report
- Fineotex Chemical Limited, Official Financial Results
- Fineotex Chemical Limited, Official Investor Relations
Disclaimer
The information presented above on Fineotex Chemical has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts and official corporate disclosures. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and updated financial data, ratios and disclosures before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.